Cargando…
Resolution of an unexpected ABO typing discrepancy in a 9‐month‐old patient with juvenile myelomonocytic leukemia
In the post–hematopoietic transplant period, the components of the ABO blood type (antigen testing of erythrocytes and plasma antibody testing) can provide important insights into a patient's immunologic status.
Autores principales: | Hermelin, Daniela, Zhang, Danmei, Blackall, Douglas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752456/ https://www.ncbi.nlm.nih.gov/pubmed/33363740 http://dx.doi.org/10.1002/ccr3.3101 |
Ejemplares similares
-
The Genomic Landscape of Juvenile Myelomonocytic Leukemia
por: Stieglitz, Elliot, et al.
Publicado: (2015) -
Current Treatment of Juvenile Myelomonocytic Leukemia
por: Mayerhofer, Christina, et al.
Publicado: (2021) -
Molecular Targets for the Treatment of Juvenile Myelomonocytic Leukemia
por: Liu, Xiaoling, et al.
Publicado: (2012) -
Genomic and Epigenomic Landscape of Juvenile Myelomonocytic Leukemia
por: Fiñana, Claudia, et al.
Publicado: (2022) -
Novel splicing-factor mutations in juvenile myelomonocytic leukemia
por: Takita, J, et al.
Publicado: (2012)